Samsara Therapeutics Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Samsara Therapeutics is a biotechnology research company based in Oxford, England, focused on activating autophagy to address age-related neurodegenerative diseases. The company aims to slow the progression of debilitating conditions by targeting autophagy-related cellular processes. Its work is focused on applying autophagy biology to neurodegenerative diseases. In June 2023, the company announced the appointment of Professor Dame Pamela Shaw to its scientific advisory board, bringing expertise in ALS/MND. The organization has engaged in collaborations with research foundations, including a partnership with the CMT Research Foundation to optimize pipeline autophagy compounds.